Search results for "diet"

showing 10 items of 4602 documents

COVID Obesity: A One-Year Narrative Review

2021

On 11 March 2020, coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO). This study focuses on a narrative review about the illness during the first year of the pandemic in relation to obesity. Databases were used to search studies published up to 8 December 2020. In total, 4430 articles and other scientific literature were found, and 24 articles were included in this one-year narrative review. The mean BMI value of severe COVID-19 patients ranged from 24.5 to 33.4 kg/m2, versus 2 for non-severe patients. Articles using the terms obesity or overweight without indicating the BMI value in these patients were common, but this is not useful, as the a…

obesityReviewComorbidityScientific literature030204 cardiovascular system & hematologyOverweightSeverity of Illness IndexCOVID obesityBody Mass IndexBMI03 medical and health sciences0302 clinical medicinePandemicSeverity of illnessHumansoverweightMedicineTX341-641030212 general & internal medicineEpidemiologiaPandemicsNutrition and DieteticsSARS-CoV-2Nutrition. Foods and food supplybusiness.industryCOVID-19Anthropometrymedicine.diseaseObesityComorbiditynutritionTrastorns de la nutricióObesitatmedicine.symptombusinessBody mass indexFood ScienceDemographyNutrients
researchProduct

Adipokines in obesity and metabolic diseases

2020

Adipose tissue secretes many adipokines that regulate important physiological functions. Growing studies have highlighted that these bioactive molecules may contribute to the development of metabolic and cardiovascular diseases. Adipokines exert systemic metabolic effects and independent activity on numerous cells of the cardiovascular system, including cardiomyocytes and vascular cell walls. Adiponectin shows anti-inflammatory and anti-atherosclerotic activity on blood vessels. Conversely, resistin is endowed with pro-inflammatory effects and stimulates the proliferation of smooth muscle cells, thus promoting the development of atherosclerotic plaque. Leptin plays an important role in card…

obesitySettore BIO/16 - Anatomia Umanabusiness.industryBiochemistry (medical)AdipokinePlant ScienceBioinformaticsmedicine.diseaseSettore BIO/09 - FisiologiaObesityAdipokines adipose tissue metabolic syndrome obesity cardiovascular disease.General Biochemistry Genetics and Molecular Biologymetabolic syndromeadipose tissueSettore MED/18 - Chirurgia GeneraleAdipokineslcsh:Biology (General)cardiovascular diseaseAdipokineSettore BIO/14 - FarmacologiaMedicineSettore MED/49 - Scienze Tecniche Dietetiche Applicatebusinesslcsh:QH301-705.5Journal of Biological Research
researchProduct

The association of cannabis use with fast-food consumption, overweight, and obesity among adolescents aged 12-15 years from 28 countries

2022

Background: Cannabis legalization and use have risen globally. However, the association between cannabis use, eating behaviors and body weight among adolescents is yet unexplored. Objectives: This study examined the association between cannabis use, fast-food consumption, overweight and obesity in 28 countries using data from the 2010–2016 Global School-Based Student Health Survey. Methods: Multivariable logistic regression and meta-analysis were performed among a sample of 83,726 adolescents (48.7% females) aged 12–15 years, mean (SD) age of 13.8 (0.9) years. Results: The overall prevalence of cannabis use (in past 30 days) and fast-food consumption (in past 7 days) were 2.8% and 57.3% res…

obesityTOBACCOOUTCOMESHealth (social science)Science & TechnologySubstance AbuseMedicine (miscellaneous)ALCOHOLfast-food consumptionDIETCannabis adolescence obesity overweight fast-food consumptionBODY-MASS INDEXYOUTHCARDIOVASCULAR RISK-FACTORSoverweightWEIGHT STIGMAadolescenceHEALTHLife Sciences & BiomedicineMEDICAL MARIJUANA LAWSCannabis
researchProduct

The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.

2015

Objectives:\ud The corticotrophin-releasing factor (CRF)/urocortin system is expressed in the adipose tissue of mammals, but its functional role in this tissue remains unknown.\ud \ud Methods:\ud Pharmacological manipulation of the activity of CRF receptors, CRF1 and CRF2, was performed in 3T3L1 white pre-adipocytes and T37i brown pre-adipocytes during in vitro differentiation. The expression of genes of the CRF/urocortin system and of markers of white and brown adipocytes was evaluated along with mitochondrial biogenesis and cellular oxygen consumption. Metabolic evaluation of corticosterone-deficient or supplemented Crhr1-null (Crhr1−/−) mice and their wild-type controls was performed alo…

obesitycrf1Corticotropin-Releasing Hormonecrf2Endocrinology Diabetes and MetabolismIMPAIRED STRESS-RESPONSE[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionAdipocytes WhiteMedicine (miscellaneous)urocortinWhite adipose tissueMOUSEMicebrown adiposte tissue0302 clinical medicineBrowningUrocortinsUrocortin0303 health sciencesNutrition and Dietetics[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismParacrine mechanisms[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismImmunohistochemistryADIPOCYTESAdipocytes BrownADIPOSE-TISSUESKELETAL-MUSCLEhormones hormone substitutes and hormone antagonistsSignal TransductionEXPRESSIONmedicine.medical_specialtyendocrine systemTHERMOGENESISBiologycrfReceptors Corticotropin-Releasing Hormone03 medical and health scienceswhite adipose tissueInternal medicine3T3-L1 CellsmedicineAnimalsRNA MessengerGLUCOCORTICOIDS030304 developmental biologyENERGY HOMEOSTASISCorticotrophin releasing factoradipose plasticityPigments BiologicalUROCORTIN-II GENEQPEndocrinologyGene Expression Regulation[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

The effects of physical activity and diet change on intracellular lipids and metabolism in mice with diet-induced obesity

2014

obesitydiet changemicerasvatphysical activityylipainoliikuntafysiologiahiiretliikuntainsuliiniresistenssiruokavaliotlipidsaikuisiän diabetesinsulin resistancelihavuusmetabolismaineenvaihduntametabolinen oireyhtymäaikuistyypin diabetesfyysinen aktiivisuus
researchProduct

Endothelial Function in Obese Patients Treated with Bariatric Surgery

2020

Antonio Maria Borzì,1,2,* Carola Buscemi,3,4,* Davide Corleo,3,4 Cristiana Randazzo,3,4 Giuseppe Rosafio,3,4 Gianni Pantuso,5 Silvio Buscemi3,4 1Department of Clinical and Experimental Medicine, Specialization School in Geriatrics, University of Catania, Catania, Italy; 2Specialization School in Geriatrics, Catania, Italy; 3Dipartimento di Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo, Palerno, Italy; 4Unit of Malattie Endocrine, del Ricambio e della Nutrizione, Policlinico University Hospital, Palermo, Italy; 5Dipartimento di Discipline Chirurgiche e Odontostomatologiche (DICHIRONS), Unit of Chirurgia Onco…

obesityendothelial functionRC581-951bariatric surgerySpecialties of internal medicineSettore MED/49 - Scienze Tecniche Dietetiche Applicatemedical nutrition therapyDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
researchProduct

High-intensity interval training and moderate intensity training with exogenous adenosine counteract development of obesity in rats

2022

Objectives High-Intensity Interval Training (HIIT) and Moderate Intensity Training (MIT) can combat the obesity epidemic. However, studies comparing their effects on obesity show controversial findings regarding weight loss. Adenosine has emerged as a possible, novel therapeutic agent to treat obesity, but more preclinical studies on its efficacy are needed. Therefore, the objectives of this study were to compare the effects of HIIT and MIT on obesity, and further to determine the dose-dependent effects of adenosine on body weight. Equipment and methods We induced obesity in male Wistar rats with high-fat diet (HFD) and monitored development of obesity by comparing the weight to rats on nor…

obesityexercisekuntoliikuntaadenosiiniintervalliharjoitteluModerate Intensity Training (MIT)painonhallintaenergy intakelihavuusOrthopedics and Sports Medicineexogenous adenosineHigh-Intensity Interval Training (HIIT)weight losskoe-eläinmallitisocaloricHigh Fat diet (HFD)
researchProduct

Effects of exercise and diet on sleep among overweight and obese men with chronic insomnia symptoms

2016

obesityexercisemalesylipainoliikuntaruokavaliotkeski-ikäisetunettomuuschronic insomnia symptomsliikuntalääketiedeoverweightsleep onsetlihavuusmiehetdietravitsemusunihäiriötfyysinen aktiivisuusnukahtaminen
researchProduct

New developments in the pathogenesis of obesity-induced hypertension

2015

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential …

obesityhypertensionPhysiologyAppetiteDiseaseGut floraleptinDiabetes mellitusInternal Medicinemedicinea-MSHAnimalsHumanssaltEpigeneticsExercisesun lightsympathetic nervous systembiologygut microbiotabusiness.industryLeptinpotassiumPotassium DietaryType 2 Diabetes MellitusCancerSodium DietaryProtective Factorsmedicine.diseasebiology.organism_classificationObesityDiabetes Mellitus Type 2Cardiovascular DiseasesImmunologyReceptor Melanocortin Type 4Gene-Environment InteractionCardiology and Cardiovascular Medicinebusiness
researchProduct

Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity

2021

Introduction: The recent global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 7 million people worldwide and been associated with more than 400,000 deaths. No clear information is known about all the potential risk factors for COVID-19 or what factors adversely influence its clinical course and mortality. Therefore, we analyzed the role of obesity, type 2 diabetes, and hypertension as risk factors for COVID-19. Methods: We identified articles for inclusion by searching PubMed and Google Scholar (last accessed 15 June 2020). Retrospective review of literature. Analysis of epidemiological data co…

obesityhypertensionrisk factordiabeteSARS-CoV-2COVID-19Settore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct